The burgeoning burden of respiratory syncytial virus among children.
about
Determinants of early life immune responses to RSV infectionA Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial VirusDefining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western CountriesWhat Are the Most Powerful Immunogen Design Vaccine Strategies?A multi-laboratory study of diverse RSV neutralization assays indicates feasibility for harmonization with an international standard.The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom.A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSVRespiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registriesSafety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults.Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation.IL-17E (IL-25) and IL-17RB promote respiratory syncytial virus-induced pulmonary diseaseAdvances in and the potential of vaccines for respiratory syncytial virus.Vaccines for children and adults with chronic lung disease: efficacy against acute exacerbations.Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein.Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease.Development of a Global Respiratory Severity Score for Respiratory Syncytial Virus Infection in Infants.A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.Roles of Non-coding RNAs in Respiratory Syncytial Virus (RSV) Infection.Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation.Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus.Incidence, Morbidity, and Costs of Human Metapneumovirus Infection in Hospitalized Children.Cytokine responses in primary and secondary respiratory syncytial virus infections.Development of a sensitive loop-mediated isothermal amplification assay that provides specimen-to-result diagnosis of respiratory syncytial virus infection in 30 minutes.A neutralization assay for respiratory syncytial virus using a quantitative PCR-based endpoint assessment.Viral aetiology and clinical outcomes in hospitalised infants presenting with respiratory distress.Children with celiac disease are more likely to have attended hospital for prior respiratory syncytial virus infection.CD38 modulates respiratory syncytial virus-driven pro-inflammatory processes in human monocyte-derived dendritic cells.Safety, Tolerability, and Pharmacokinetics of MEDI8897, an Extended Half-Life Single-Dose Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants.Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System.Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United StatesNucleolar Relocalization of RBM14 by Influenza A Virus NS1 Protein
P2860
Q26764790-6FB543AF-F0A6-4424-B73C-FC77C5694219Q27305097-36731B81-20F7-4AFD-B390-196DD5CF391CQ28069415-829CADDF-A510-4F8D-886A-04F6FBA8F352Q28729792-79118F1C-0F8F-458D-9D24-C1133AABFB0EQ33712575-81A9389F-7659-4169-BF68-8EFAB55752E5Q33732535-A0B3B9FB-1548-4F78-A9A5-B77E8B5C6497Q35535626-8A84ACF2-D26E-471D-8436-BB2989D8FA1CQ35819905-5DF0293B-8164-46D6-9960-62CF5AA87580Q36029158-5A8F78EE-1B5F-4D90-A46C-8D9C494F2890Q36989863-85FE3AE8-1A2B-46C5-BB09-90F5DC4F6A47Q37669850-65910613-8693-44C1-A7CC-62DEB981CA8DQ37690464-F6785259-9287-4681-8A96-31BEF214F670Q37700171-FF3A2760-47DF-445D-AF86-7EE2E1AF10FAQ38130514-7042C93A-AAE4-46C5-8E10-D90ACA9D08E1Q38168915-B22BBF92-EB5A-4947-8367-C206395ABC31Q38394731-477FE87C-4FE7-40D4-892B-AB3249E3CBCBQ38998557-B9D1E33B-0C05-4020-928B-BC9BAC7CA9ABQ39067427-0AC08BFD-755B-4512-AD9F-716CE80B9135Q39362187-342BD513-85B4-4BDD-8C2E-25B95552F9D8Q39395437-2660894E-8287-499C-B5FB-77C0CDFC5B60Q40139880-EFB24514-6277-4EB7-AD42-4C344BFFEFB6Q40244825-7EC74137-C499-4A0D-97BA-AFCE2EFA710AQ40353525-42EDF372-DE53-4BCB-B895-10C5C77BF6AAQ40500669-C32D3DA0-EBAC-4E3D-9EA7-32084A7ED69AQ40789579-47FF2AC4-52FE-4321-BC2A-2E1AF523AEDFQ42080351-93B98EC8-9AB5-4E53-8F28-58DB34E0A1EFQ42169918-E0644088-6823-410B-A828-9A1D456CF3CAQ42233110-A8094226-C68E-4398-8431-F209D881D722Q42238116-F14E666B-5BD9-4EFA-8044-4871EE2A5CAFQ45324208-F7059179-0363-4660-98D5-B7C674D772B2Q47548690-A03BBC67-592F-4403-85E8-45D83559D8AFQ55514867-39B4AEEE-A347-43CF-9043-D2FCA6D9BD44Q55534670-F642A054-FB13-4F43-86E8-EA1E30801EB3Q56967587-1CFC2172-655C-4364-854C-7148D0CD76C2Q59126800-960CC31A-0A5F-4CA0-8F69-9B27BB1E6B34
P2860
The burgeoning burden of respiratory syncytial virus among children.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The burgeoning burden of respiratory syncytial virus among children.
@en
The burgeoning burden of respiratory syncytial virus among children.
@nl
type
label
The burgeoning burden of respiratory syncytial virus among children.
@en
The burgeoning burden of respiratory syncytial virus among children.
@nl
prefLabel
The burgeoning burden of respiratory syncytial virus among children.
@en
The burgeoning burden of respiratory syncytial virus among children.
@nl
P1476
The burgeoning burden of respiratory syncytial virus among children.
@en
P2093
Caroline Breese Hall
P356
10.2174/187152612800100099
P577
2012-04-01T00:00:00Z